Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Without coverage, semaglutide can be costly
Across the broader GLP-1 class, approved indications include type 2 diabetes for most compounds, chronic weight management for products like Wegovy, Saxenda, and Zepbound, cardiovascular risk reduction in type 2 diabetes for several products, and obstructive sleep apnea in adults with obesity for Zepbound as of 2024
Weight loss from Zoloft may require dosage adjustments
Most will reship at no charge for confirmed heat exposure
Galsgaard KD, Pedersen J, Knop FK, Holst JJ, Wewer Albrechtsen NJ
Meanwhile, liraglutide's share decreased from 42% to 12% among users with diabetes and from 58% to 21% among those without diabetes, although its estimated absolute number of users without diabetes increased
US$ 29.87
US$ 28.79
US$ 24.09
